Jerome Hahn Kim is Director General of the International Vaccine Institute (IVI).[1][2]

He was educated at University of Hawaiʻi at Mānoa where he studied Biology and History, the Yale School of Medicine (MD, 1984), and completed his training at Duke University Medical Center.[3][4] Prior to IVI, Dr. Kim led the US Army's advanced development program for HIV vaccines, the RV 144 HIV vaccine trial, and a molecular virology laboratory at Walter Reed Army Institute of Research.[3]

He has an h-index of 76 according to Google Scholar.[5]

References

  1. ↑ Ledford, Heidi (2021). "Why COVID vaccines are so difficult to compare". Nature. 591 (7848): 16–17. Bibcode:2021Natur.591...16L. doi:10.1038/d41586-021-00409-0. PMID 33623151. S2CID 232039872. Retrieved 15 July 2021.
  2. ↑ "India's Covid Curve Could Raise the World's". The Wall Street Journal. Retrieved 15 July 2021.
  3. 1 2 "Scientific Advisory Board". Vaccitech. Retrieved 15 July 2021.
  4. ↑ "Jerome Kim Named to Head South Korea's International Vaccine Institute". John A. Burns School of Medicine. Retrieved 15 July 2021.
  5. ↑ "Jerome Kim". Google Scholar. Retrieved 13 November 2023.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.